 NEW YORK and SAN DIEGO, March 15, 2021 GLOBE NEWSWIRE -- Wolf Haldenstein Adler Freeman Herz LLP announces that it is investigating GenMark Diagnostics GenMark NASDAQ: GNMK regarding possible breaches of fiduciary duties and other violations of law related to GenMarks agreement to be acquired by F. Hoffman La-Roche Ltd. Under the terms of the merger, GenMark shareholders will receive 24.05 per share. 